SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-20-005434
Filing Date
2020-05-18
Accepted
2020-05-15 21:37:56
Documents
18

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 3376083
2 filename2.htm EX-10.2 724474
3 filename3.htm EX-21.1 3564
4 GRAPHIC g862976g02a41.jpg GRAPHIC 21895
5 GRAPHIC g862976g15b66.jpg GRAPHIC 102340
6 GRAPHIC g862976g16e84.jpg GRAPHIC 114376
7 GRAPHIC g862976g19e19.jpg GRAPHIC 62983
8 GRAPHIC g862976g19t16.jpg GRAPHIC 87259
9 GRAPHIC g862976g23a43.jpg GRAPHIC 165145
10 GRAPHIC g862976g24o70.jpg GRAPHIC 63045
11 GRAPHIC g862976g33i81.jpg GRAPHIC 69830
12 GRAPHIC g862976g51n87.jpg GRAPHIC 50291
13 GRAPHIC g862976g70e63.jpg GRAPHIC 24785
14 GRAPHIC g862976g71r75.jpg GRAPHIC 82007
15 GRAPHIC g862976g72f51.jpg GRAPHIC 65080
16 GRAPHIC g862976g72n67.jpg GRAPHIC 123014
17 GRAPHIC g862976g82g10.jpg GRAPHIC 136943
18 GRAPHIC g862976g94a15.jpg GRAPHIC 218716
  Complete submission text file 0000950123-20-005434.txt   6018823
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-03047 | Film No.: 20887589
SIC: 2834 Pharmaceutical Preparations